About Haixing Wang
Form D filings for Conjupro Biotherapeutics in 2023 list Haixing Wang as executive officer.
Haixing Wang first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Haixing Wang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Haixing Wang works with at each company, as listed on that company's latest Form D.
Conjupro Biotherapeutics Inc. · Form D, Sep 12, 2023
QW
Qingxi Wang
CEO and director